GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (XSWX:EVE) » Definitions » Median PS Value

Evolva Holding (XSWX:EVE) Median PS Value : CHF69.11 (As of Apr. 29, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Evolva Holding Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Evolva Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF2.652. Evolva Holding's 10-Year median PS Ratio is 26.0596. Therefore, the Median PS Value for today is CHF69.11.

As of today (2024-04-29), Evolva Holding's share price is CHF0.946. Evolva Holding's Median PS Value is CHF69.11. Therefore, Evolva Holding's Price to Median PS Value for today is 0.01.

The historical rank and industry rank for Evolva Holding's Median PS Value or its related term are showing as below:

XSWX:EVE' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01   Med: 1.12   Max: 1.49
Current: 0.01

During the past 13 years, the highest Price to Median PS Value of Evolva Holding was 1.49. The lowest was 0.01. And the median was 1.12.

XSWX:EVE's Price-to-Median-PS-Value is ranked better than
99.61% of 259 companies
in the Biotechnology industry
Industry Median: 0.65 vs XSWX:EVE: 0.01

Evolva Holding Median PS Value Historical Data

The historical data trend for Evolva Holding's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding Median PS Value Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.56 69.49 44.56 53.42 69.11

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 53.42 - 69.11 -

Competitive Comparison of Evolva Holding's Median PS Value

For the Biotechnology subindustry, Evolva Holding's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Evolva Holding's Price-to-Median-PS-Value falls into.



Evolva Holding Median PS Value Calculation

Evolva Holding's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.652*26.0596
=69.11

10-Year Median PS Ratio is 26.0596.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was CHF2.652.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding  (XSWX:EVE) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Evolva Holding's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.946/69.11
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding Median PS Value Related Terms

Thank you for viewing the detailed overview of Evolva Holding's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding (XSWX:EVE) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.